ARCT logo

Arcturus Therapeutics Holdings Inc. (ARCT)

Profile

Full Name

Arcturus Therapeutics Holdings Inc.

Ticker

NASDAQ: ARCT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 22, 2013

Indexes

Not included

Website

http://arcturusrx.com

Employees

174

Key Details

Price

$14.94(-0.07%)

Market cap

$405.18M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$138.39M(-12.27% YoY)

Annual EPS

-$3.00(-167.86% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.94
    ARCT price is $14.94

    30-Day Relative Volume

    0.74
    ARCT 30-day relative volume is 0.74

    Price Performance

    Price Most recent change

    -0.07%
    ARCT price was down -0.07% on Jul 25, 2025

    Price YTD change

    -11.96%
    ARCT price is down -11.96% since January 1st

    Price 1-year change

    -34.99%
    ARCT price is down -34.99% year-on-year

    Price 3-year change

    -10.97%
    ARCT price is down -10.97% over the past 3 years

    Price Range

    Price All-time high

    $188.72
    ARCT price is currently -92.08% below its historical high of $188.72

    Price 3-year low

    $8.04
    ARCT price is currently +85.82% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $405.18M
    ARCT market capitalization is $405.18 million

    Market cap 3-year change

    -8.65%
    ARCT market capitalization is down -8.65% over the past 3 years

    Market cap All-time high

    $3.06B
    ARCT market capitalization is currently -86.77% below its historical high of $3.06 billion

    Market cap sector rank

    62.49%
    ARCT market capitalization is higher than 62.49% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.29%
    ARCT shares outstanding is up +0.29% year-on-year

    Shares Outstanding 3-Year Change

    +2.6%
    ARCT shares outstanding is up +2.6% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.42
    ARCT beta is 1.42

    200-day SMA

    $15.21
    ARCT price is currently -1.76% below its 200-day simple moving average

    50-day SMA

    $13.04
    ARCT price is currently +14.61% above its 50-day simple moving average

    RSI

    60.56
    ARCT 14-day relative strength index is 60.56

    Volume

    0.74
    ARCT 30-day relative volume is 0.74

    ATR

    $0.85
    ARCT average true range is $0.85

    10-day Historical Volatility

    58.83%
    ARCT 10-day historical volatility is 58.83%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $138.39M
    ARCT annual revenue is $138.39 million

    Revenue Analysts estimate

    $80.94M
    ARCT annual revenue is currently +70.97% higher than the consensus analysts' forecast

    Revenue 1-year change

    -12.27%
    ARCT annual revenue is down -12.27% year-on-year

    Revenue Sector rank

    59.54%
    ARCT annual revenue is higher than 59.54% of companies in Healthcare sector

    EPS

    EPS

    -$3.00
    ARCT annual earnings per share is -$3.00

    EPS Analysts estimate

    -$3.31
    ARCT annual earnings per share is currently -9.47% lower than the consensus analysts' forecast

    EPS 1-year change

    -167.86%
    ARCT annual earnings per share is down -167.86% year-on-year

    EPS Sector rank

    29.88%
    ARCT annual earnings per share is higher than 29.88% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ARCT annual gross profit value is unknown

    Gross margin

    -
    ARCT annual gross profit margin value is unknown

    Operating profit

    -$95.67M
    ARCT annual operating income is -$95.67 million

    Operating margin

    -69.13%
    ARCT annual operating profit margin is -69.13%

    Net income

    -$80.94M
    ARCT annual net profit is -$80.94 million

    Net margin

    -58.49%
    ARCT annual net profit margin is -58.49%

    Expenses

    Total expenses

    $234.06M
    ARCT annual total expenses is $234.06 million

    Operating expenses

    $234.06M
    ARCT annual total operating expenses is $234.06 million

    Cost of goods sold

    -
    ARCT annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $52.82M
    ARCT annual SGA is $52.82 million

    Depreciation and amortization

    $3.54M
    ARCT annual depreciation & amortization is $3.54 million

    Interest expense

    $0.00
    ARCT annual interest expense is $0.00

    Income tax

    -$4000.00
    ARCT annual income tax is -$4000.00

    EBIT & EBITDA

    EBIT

    -$80.94M
    ARCT annual earnings before interest & taxes is -$80.94 million

    EBITDA

    -$77.40M
    ARCT annual EBITDA is -$77.40 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $344.07M
    ARCT annual total assets is $344.07 million

    Non current assets

    $38.09M
    ARCT annual long term assets is $38.09 million

    Current assets

    $305.98M
    ARCT annual total current assets is $305.98 million

    Cash and cash equivalents

    $237.03M
    ARCT annual cash & cash equivalents is $237.03 million

    Accounts receivable

    $3.97M
    ARCT annual accounts receivable is $3.97 million

    Inventory

    -
    ARCT annual inventory value is unknown

    Liabilities

    Total liabilities

    $103.09M
    ARCT annual total liabilities is $103.09 million

    Long term liabilities

    $37.60M
    ARCT annual total long term liabilities is $37.60 million

    Current liabilities

    $65.49M
    ARCT annual total current liabilities is $65.49 million

    Accounts payable

    $7.19M
    ARCT annual accounts payable is $7.19 million

    Debt

    Total debt

    $28.55M
    ARCT annual total debt is $28.55 million

    Total debt 1-year change

    -5.51%
    ARCT annual total debt is down -5.51% year-on-year

    Long term debt

    $25.00M
    ARCT annual long term debt is $25.00 million

    Short term debt

    $3.55M
    ARCT annual short term debt is $3.55 million

    Equity & Capital

    Shareholders equity

    $240.98M
    ARCT annual stockholders equity is $240.98 million

    Book value

    $240.98M
    ARCT annual book value is $240.98 million

    Retained earnings

    -$448.81M
    ARCT annual retained earnings is -$448.81 million

    Working capital

    $240.49M
    ARCT annual working capital is $240.49 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$59.75M
    ARCT annual cash flow from operations is -$59.75 million

    Cash from operations 1-year change

    -230.11%
    ARCT annual cash flow from operations is down -230.11% year-on-year

    Cash from investing

    -$648.00K
    ARCT annual cash flow from investing activities is -$648.00 thousand

    Cash from investing 1-year change

    +77.66%
    ARCT annual cash flow from investing activities is up +77.66% year-on-year

    Cash from financing

    $5.42M
    ARCT annual cash flow from financing activities is $5.42 million

    Cash from financing 1-year change

    +122.49%
    ARCT annual cash flow from financing activities is up +122.49% year-on-year

    CAPEX

    CAPEX

    $648.00K
    ARCT annual capital expenditures is $648.00 thousand

    CAPEX 1-year change

    -77.66%
    ARCT annual capital expenditures is down -77.66% year-on-year

    Free Cash Flow

    Free cash flow

    -$60.40M
    ARCT annual free cash flow is -$60.40 million

    Free cash flow 1-year change

    -187.6%
    ARCT annual free cash flow is down -187.6% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ARCT annual gross profit margin value is unknown

    Operating margin

    -69.13%
    ARCT annual operating profit margin is -69.13%

    Net margin

    -58.49%
    ARCT annual net profit margin is -58.49%

    ROA & ROE

    ROA

    -20.93%
    ARCT annual return on assets is -20.93%

    ROE

    -31.16%
    ARCT annual return on equity is -31.16%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ARCT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ARCT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.73
    ARCT price to book ratio is 1.73

    PB ratio Sector rank

    50.54%
    ARCT price to book ratio is higher than 50.54% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.09
    ARCT price to sales ratio is 3.09

    PS ratio Sector rank

    49.73%
    ARCT price to sales ratio is higher than 49.73% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $230.89M
    ARCT enterprise value is $230.89 million

    Enterprise value Sector rank

    54.88%
    ARCT enterprise value is higher than 54.88% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.84
    ARCT EV/EBITDA is -3.84

    EV/EBITDA Sector rank

    29.67%
    ARCT EV/EBITDA is higher than 29.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.67
    ARCT annual current ratio is 4.67

    Quick ratio

    -
    ARCT annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ARCT annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ARCT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ARCT piotroski f-score value is unknown

    Altman Z-Score

    1.00
    ARCT altman z-score is 1.00

    Analyst ratings

    Recent major analysts updates

    Jul 2, 25 Scotiabank
    Sector Outperform
    May 28, 25 Scotiabank
    Sector Outperform
    May 14, 25 Wells Fargo
    Overweight
    May 13, 25 Canaccord Genuity
    Buy
    Apr 10, 25 HC Wainwright & Co.
    Buy
    Mar 10, 25 Canaccord Genuity
    Buy
    Mar 7, 25 Wells Fargo
    Overweight
    Mar 7, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Cantor Fitzgerald
    Overweight
    Feb 18, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with ARCT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Arcturus Therapeutics Holdings Inc.?
    • Does Arcturus Therapeutics Holdings Inc. pay dividends?
    • What sector is Arcturus Therapeutics Holdings Inc. in?
    • What industry is Arcturus Therapeutics Holdings Inc. in?
    • What country is Arcturus Therapeutics Holdings Inc. based in?
    • When did Arcturus Therapeutics Holdings Inc. go public?
    • Is Arcturus Therapeutics Holdings Inc. in the S&P 500?
    • Is Arcturus Therapeutics Holdings Inc. in the NASDAQ 100?
    • Is Arcturus Therapeutics Holdings Inc. in the Dow Jones?
    • When was Arcturus Therapeutics Holdings Inc.'s last earnings report?
    • When does Arcturus Therapeutics Holdings Inc. report earnings?

    What is the ticker symbol for Arcturus Therapeutics Holdings Inc.?

    The ticker symbol for Arcturus Therapeutics Holdings Inc. is NASDAQ:ARCT

    Does Arcturus Therapeutics Holdings Inc. pay dividends?

    No, Arcturus Therapeutics Holdings Inc. does not pay dividends

    What sector is Arcturus Therapeutics Holdings Inc. in?

    Arcturus Therapeutics Holdings Inc. is in the Healthcare sector

    What industry is Arcturus Therapeutics Holdings Inc. in?

    Arcturus Therapeutics Holdings Inc. is in the Biotechnology industry

    What country is Arcturus Therapeutics Holdings Inc. based in?

    Arcturus Therapeutics Holdings Inc. is headquartered in United States

    When did Arcturus Therapeutics Holdings Inc. go public?

    Arcturus Therapeutics Holdings Inc.'s initial public offering (IPO) was on May 22, 2013

    Is Arcturus Therapeutics Holdings Inc. in the S&P 500?

    No, Arcturus Therapeutics Holdings Inc. is not included in the S&P 500 index

    Is Arcturus Therapeutics Holdings Inc. in the NASDAQ 100?

    No, Arcturus Therapeutics Holdings Inc. is not included in the NASDAQ 100 index

    Is Arcturus Therapeutics Holdings Inc. in the Dow Jones?

    No, Arcturus Therapeutics Holdings Inc. is not included in the Dow Jones index

    When was Arcturus Therapeutics Holdings Inc.'s last earnings report?

    Arcturus Therapeutics Holdings Inc.'s most recent earnings report was on May 12, 2025

    When does Arcturus Therapeutics Holdings Inc. report earnings?

    The next expected earnings date for Arcturus Therapeutics Holdings Inc. is August 5, 2025
    On this page